HOME › Research Insight › New Product Launches and Merger & Acquisitions are the Key Growth Strategies in the Global Tissue Diagnostics Market
New Product Launches and Merger & Acquisitions are the Key Growth Strategies in the Global Tissue Diagnostics Market
Tissue diagnostics is an important technique to diagnose cancer patients and it is also used in the pharmaceutical research. Tissue based diagnostic tests play a vital role in the modern medical practice, they are conducted with the help of various instruments and consumables for the diagnosis of a number of diseases.
Tissue diagnostic products like instruments and consumables approved for use in the tissue based diagnostics tests have high quality standards. Further, there is a high degree of consolidation in the tissue diagnostics market with few large players dominating the entire market. Stringent regulatory requirements and high degree of consolidation are important entry barriers for new entrants in this market. Small and mid-size players have a small share of the market and their business interests remain concentrated in local markets across emerging geographies.
Roche Diagnostics (Switzerland), Agilent Technologies (U.S.), and Danaher Corporation (U.S.) are the market leaders in the tissue diagnostics market. These companies have business interests across the globe with the U.S. accounting for the largest share of their combined revenues followed by Europe.
New product launches and Merger & Acquisitions are the key growth strategies adopted by major players in the tissue diagnostics market. The strategy of new product launches was mainly adopted by Roche Diagnostics (Switzerland), Agilent Technologies (U.S.), and Danaher Corporation (U.S.). In tissue diagnostics market important players are acquired by some major companies. Merger & Acquisitions strategy was mainly adopted by Danaher Corporation (U.S.) and Agilent Technologies (U.S.). Danaher Corporation acquired Leica Biosystems and Beckman Coulter, and Agilent Technologies acquired Dako. Companies adopted these strategies in order to expand their product portfolio and strengthen their market presence.
Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252